BioCentury
ARTICLE | Clinical News

Transdur-Sufentanil: Phase IIb data

March 23, 2009 7:00 AM UTC

Data from an open-label, U.S. Phase IIb trial in 74 patients showed that 2 dose titration regimens for converting opioid-experienced patients to once-weekly Transdur-Sufentanil patch achieved the desi...